Aficamten for Drug-Refractory Severe Obstructive Hypertrophic Cardiomyopathy in Patients Receiving Disopyramide: REDWOOD-HCM Cohort 3

REDWOOD-HCM INVESTIGATORS

Research output: Contribution to journalArticlepeer-review

2 Scopus citations
Original languageEnglish (US)
Pages (from-to)1576-1582
Number of pages7
JournalJournal of Cardiac Failure
Volume29
Issue number11
DOIs
StatePublished - Nov 2023

Keywords

  • Aficamten
  • REDWOOD-HCM
  • obstructive hypertrophic cardiomyopathy
  • refractory obstructive hypertrophic cardiomyopathy

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this